Maintaining Hold on Accenture: A Clean Beat and a Record Cash Year Meet a Decelerating FY26 Guide and an $865M Restructuring — Quality Is Cheap, But the Growth Algorithm Just Stepped Down
Key Takeaways
- Accenture closed FY25 at the top of its guide — Q4 revenue $17.6B (+7% USD, +4.5% LC; +6% ex-federal), adjusted EPS $3.03 (+9%) beating consensus by ~3.4%, and a record full-year free cash flow of $10.9B (+26%, a 1.4x FCF/NI ratio). The cash machine is firing on all cylinders.
- But the first FY26 guide is the headline: +2–5% local-currency revenue growth (3–6% ex-federal) and adjusted EPS of $13.52–$13.90 (+5–8%) — a clear step-down from FY25's +7%. The federal/DOGE drag is now sized (1–1.5% for FY26, anniversarying at the end of Q3), removing the un-bounded overhang we flagged in June but confirming a structurally slower algorithm.
- Management initiated a ~$865M, six-month "business optimization" program — severance from a compressed-timeline talent rotation (exiting people whose skills can't be reskilled fast enough) plus the divestiture of two non-strategic acquisitions — while simultaneously committing to grow headcount across all three markets in FY26. The juxtaposition is the whole AI story in one move: rotate the pyramid, don't shrink it.
- The AI scoreboard improved materially: advanced AI (GenAI + agentic + physical) revenue tripled to $2.7B and bookings nearly doubled to $5.9B in FY25, and management says GenAI pricing is "accretive overall to Accenture's average." Julie Sweet was emphatic that AI is "expansionary, not deflationary." The bull's rebuttal to cannibalization now has numbers — but gross margin compressed again (31.9% vs. 32.5%).
- Rating: Maintaining Hold. The June overhang we cited — an un-sized federal hit — is now quantified, and the stock's ~32% YTD de-rating to $239 has done real work on valuation (~17x FY26 EPS). But a freshly-confirmed deceleration to +2–5% LC, a fourth straight quarter of gross-margin slippage, and an AI transition still in "very early innings" keep the risk/reward balanced. We are closer to constructive than in June; we want one quarter of execution against the new bar before upgrading.
Results vs. Consensus
| Metric (Q4 FY25) | Actual | Consensus | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $17.6B | ~$17.4B | Beat | +1.1% |
| Revenue growth (local currency) | +4.5% | — | Top of guide | +6% ex-federal |
| Operating margin (adjusted) | 15.1% | ~15.0% | Beat | +10bps YoY |
| EPS (adjusted diluted) | $3.03 | $2.97 | Beat | +3.4% |
| New bookings | $21.3B | ~$20B | Beat | 1.2x book-to-bill |
| Free cash flow | $3.8B | n/a | Strong | $10.9B FY (+26%) |
Full-Year FY25 Scorecard
| Metric (FY25) | Result | YoY | Read |
|---|---|---|---|
| Revenue | $69.7B | +7% LC | ~$5B incremental; majority organic |
| New bookings | $80.6B | 1.2x BtB | Record 129 quarterly bookings >$100M |
| Consulting revenue | $35.1B | +5% LC | Book-to-bill softer (1.0) |
| Managed services revenue | $34.6B | +9% | Tech MS +10%, operations +6% |
| Advanced AI revenue | $2.7B | ~3x | GenAI + agentic + physical only |
| Advanced AI bookings | $5.9B | ~2x | From $3B FY23 multi-year investment |
| Operating margin (adjusted) | 15.6% | +10bps | In line with the June guide |
| EPS (adjusted) | $12.93 | +8% | Above the original FY25 guide |
| Free cash flow | $10.9B | +26% | 1.4x FCF/NI — exceptional conversion |
| Capital returned | $8.3B | — | 23 acquisitions for ~$1.5B |
Quality of Beat
- Revenue: Solid. The Q4 +4.5% LC landed at the top of the guided range and was +6% excluding the 1.5% federal drag — i.e., the commercial book is still mid-single-digit. Full-year +7% LC with the majority organic is a credible result against a macro that "did not improve over FY24."
- Margins: Mixed. Adjusted operating margin held +10bps YoY at 15.1% (Q4) and 15.6% (FY), but gross margin slipped again (31.9% vs. 32.5%) — now four consecutive quarters of gross-line erosion offset by SG&A discipline. The adjusted tax rate also stepped up (27.9% in Q4), a modest EPS headwind.
- EPS: Clean on an adjusted basis (+9% Q4, +8% FY), but note the $615M Q4 charge (with ~$250M more coming in Q1 FY26) means GAAP EPS bears a real restructuring cost the adjusted figures exclude. The cash story (1.4x FCF/NI) is the standout and is fully GAAP.
Segment Performance
By Type of Work
| Type | Q4 Revenue | Q4 Growth (LC) | Q4 Bookings (BtB) |
|---|---|---|---|
| Consulting | $8.8B | +3% | $8.9B (1.0) |
| Managed Services | $8.8B | +6% | $12.4B (1.4) |
The mix divergence we flagged in June widened. Managed services again outgrew consulting (+6% vs. +3% LC) and, critically, carried the bookings quarter — $12.4B at a 1.4x book-to-bill versus consulting's $8.9B at a flat 1.0x. The annuity book is where the demand and the backlog are. Management guided both to "low to mid-single-digit" growth in FY26, so neither is the engine that re-accelerates the algorithm; the AI-led re-rating, if it comes, has to show up as outsized growth within these buckets.
"For our guidance for FY26, both consulting and managed services are balanced. We see both of them in the low to mid-single-digit range." — Angie Park, CFO
Assessment: A 1.4x managed-services book-to-bill is a genuine positive for FY26 revenue visibility — that backlog converts. But a fourth straight quarter of consulting book-to-bill at ~1.0 confirms the discretionary/advisory side remains soft, and consulting is the higher-margin, more AI-exposed half. The mix is defensively healthy and offensively uninspiring.
By Geographic Market (Q4, LC growth)
| Market | LC Growth | Key Drivers |
|---|---|---|
| Americas | +5% (+8% ex-federal) | Banking & capital markets, industrials, software/platforms; offset by public-service decline (federal) |
| EMEA | +3% | Insurance, life sciences, utilities, consumer; UK & Spain led, Italy declined |
| Asia Pacific | +6% | Banking, public service, utilities; Japan & Australia led, energy declined |
The federal drag is now visible directly in the Americas line: reported +5% LC but +8% excluding federal — a 3-point in-region hit. EMEA decelerated to +3% (from +6% in Q3), the softest of the three, while Asia Pacific actually accelerated to +6%. The cleadership rotated geographically quarter-to-quarter, which is exactly the diversification resilience management leans on.
Assessment: Strip federal and the Americas at +8% is genuinely healthy — the U.S. commercial book is not the problem. EMEA's deceleration is the one to watch; if Europe softens further, the +2–5% FY26 algorithm tilts toward the low end.
Key Operating Metrics
| KPI | Q4 / FY25 | Read |
|---|---|---|
| New bookings (Q4) | $21.3B (1.2x BtB) | +6% USD on top of +24% Q4 FY24; 37 clients >$100M |
| Advanced AI revenue (FY) | $2.7B | Tripled YoY; 6,000+ advanced-AI projects |
| Advanced AI bookings (FY) | $5.9B | Nearly doubled YoY |
| AI & data professionals | 77,000 | From 40,000 in FY23; 550,000+ trained in GenAI fundamentals |
| Utilization | 93% | Record; management expects "low 90s" to hold |
| DSO | 47 days | Flat QoQ; tight working capital |
| Free cash flow (FY) | $10.9B | +26%; 1.4x FCF/NI |
| Cash balance | $11.5B | From $5.0B a year ago |
| Diamond clients | 305 | Largest relationships; record bookings cohort |
| Dividend (declared) | $1.63/qtr | +10% YoY; +$5B buyback authority added |
Key Topics & Management Commentary
Overall Management Tone: Confident and notably more forward-leaning on AI than at Q3, with the defensiveness of June replaced by a "we're acting decisively" posture. Management sized the federal headwind it had refused to bound a quarter ago, framed the restructuring as offense (talent rotation for growth) rather than retrenchment, and leaned hard into the "AI is expansionary" thesis with the tripled advanced-AI revenue as evidence. Where it stayed careful was on FY26 growth — the guide is unmistakably a step-down, and management did not pretend otherwise.
The FY26 Guide: A Formal Step-Down
The defining disclosure was the first FY26 outlook: +2–5% local-currency revenue growth (3–6% ex-federal), adjusted EPS of $13.52–$13.90 (+5–8%), adjusted operating margin of 15.7–15.9% (+10–30bps), and FCF of $9.8–10.5B. Management framed the range honestly — the top end assumes no change in discretionary spend; the bottom allows for deterioration.
"As you think about our guidance of 2% to 5%, excluding AFS [federal], we're at 3% to 6% for the year... at the top end of the range, there's no change in discretionary spend, while at the bottom of the range, it allows for deterioration." — Angie Park, CFO
Assessment: +2–5% LC is a clear deceleration from +7%, but it is a credible, conservatively-constructed range with the federal drag explicitly carved out and sized. The +10–30bps of margin expansion while absorbing ~$865M of restructuring and reinvesting the savings is the more impressive part of the guide. This is a "slower but still compounding" outlook, not a broken one.
The $865M Business Optimization Program
Accenture booked a $615M charge in Q4 and expects ~$250M more in Q1 FY26 (~$865M total) for a six-month program with two parts: severance tied to a compressed-timeline talent rotation (exiting people whose skills can't be reskilled fast enough for the AI era) and the divestiture of two non-strategic acquisitions. Management expects over $1B of savings, to be reinvested.
"We expect savings of over $1 billion from our business optimization program, which we expect that we will reinvest in our business and in our people... while still delivering modest margin expansion." — Julie Sweet, Chair & CEO
Crucially, this is not a net headcount reduction: management committed to growing headcount across all three markets in FY26 (it ended FY25 at ~779,000).
Assessment: This is the most important strategic action of the year and it is exactly the right shape — rotate the pyramid toward AI/data skills rather than shrink it, fund the rotation with self-help savings, and keep hiring into demand. It does, however, validate the bear's premise that the existing skill base needs material reshaping for the AI era. Execution risk on a "compressed timeline" rotation is real.
AI: Expansionary, Not Deflationary
The single most consequential exchange of the call addressed the deflation thesis head-on. Sweet rejected it outright, arguing AI follows the pattern of every prior tech wave — efficiency savings get reinvested into clients' unlimited backlog of priorities, expanding Accenture's opportunity.
"We do not see AI as deflationary. We do see and are seeing it as expansionary, similar to every tech evolution we've been through... When we can save them money by delivering our services with advanced AI, that frees up their budget to do the next things on their list." — Julie Sweet, Chair & CEO
Management reinforced this with two data points: advanced-AI revenue tripled to $2.7B, and GenAI project pricing is "accretive overall to Accenture's average."
Assessment: The expansionary framing is the bull case stated cleanly, and the tripling revenue plus accretive pricing are the best evidence yet that AI is net-positive today. But "expansionary" is a multi-year claim being made one year in, and the four-quarter gross-margin slide is the data point that doesn't fit neatly. The thesis is gaining support; it is not yet proven.
Federal: Sized, and Starting to Thaw
Having refused to bound it in June, management sized the federal drag: ~1.5% in Q4, 1–1.5% for FY26, anniversarying at the end of Q3 FY26 (it was a 20bps headwind for full-year FY25). Procurement is reportedly starting to pick up, albeit still slower than historically, and management flagged a new Palantir partnership as strategically important in federal.
"We do see procurement is now starting to pick up, although it's still slower than it has been in the past. The demand in federal is very much around modernization, consolidation, efficiency." — Julie Sweet, Chair & CEO
Assessment: Sizing the headwind and giving it an anniversary date is precisely the de-risking the stock needed — the un-bounded overhang from June is gone. A ~1–1.5% drag that rolls off after Q3 FY26 is manageable, and "procurement picking up" suggests the worst of the DOGE air-pocket is passing.
Capital Allocation Steps Up
Despite the de-rated stock, capital return accelerated: the dividend was raised 10% to $1.63/quarter, the board added $5B of buyback authority, and FY26 capital return is guided to at least $9.3B (+12%). FY26 M&A is planned at ~$3B (vs. ~$1.5B in FY25), with inorganic contribution of ~1.5%. CapEx steps up to ~$1B (+$400M), driven by real estate as the firm brings more people back to the office.
"We expect to return at least $9.3 billion through dividends and share repurchases, an increase of $1 billion, or 12% from fiscal 2025." — Angie Park, CFO
Assessment: Raising capital return 12% into a 32%-down stock is the right move and a confidence signal — buying back shares at ~17x is far better than at the ~28x of a year ago. The M&A step-up to ~$3B is notable after FY25's deliberate slowdown; it suggests management sees the target environment improving.
The "Reinvention Services" Reorg Goes Live
The September 1 consolidation of all capabilities into a single Reinvention Services unit is now live. Management reiterated the rationale — nearly 80% of large deals are multi-service — and tied it to the AI agenda: a simpler operating structure makes it easier to embed AI in both delivery and Accenture's own operations.
Assessment: The reorg is now an execution story, not an announcement. The strategic logic remains sound; the risk is disruption during rollout and reduced disclosure granularity. So far, the type-of-work and geographic detail survived this quarter's reporting — a positive sign for ongoing modelability.
Margin Architecture: Gross-Line Erosion Persists
Gross margin compressed again (31.9% vs. 32.5%), the fourth consecutive quarter of erosion, again offset by SG&A leverage (S&M 10.2% vs. 10.7%; G&A 6.6% vs. 6.8%) to deliver +10bps of adjusted operating-margin expansion. Management continues to direct attention to operating margin.
Assessment: The persistence of gross-margin erosion is the single metric most consistent with the bear's pricing-pressure thesis, and it deserves more scrutiny than management's "we manage to operating margin" framing invites. The offsetting SG&A discipline is impressive but finite — you cannot lever overhead forever. If gross margin keeps slipping, operating-margin expansion eventually stalls.
Guidance & Outlook
| Metric | FY25 Actual | FY26 Guide | Change |
|---|---|---|---|
| Revenue growth (LC) | +7% | +2% to +5% (+3–6% ex-federal) | Decelerating |
| Q1 FY26 revenue | — | $18.1–18.75B (+1–5% LC) | ~1.5% federal headwind |
| Operating margin (adj.) | 15.6% | 15.7–15.9% (+10–30bps) | Expanding |
| EPS (adjusted diluted) | $12.93 | $13.52–$13.90 (+5–8%) | Moderating |
| Free cash flow | $10.9B | $9.8–10.5B (1.2x NI) | Normalizing off a 1.4x year |
| Inorganic contribution | ~3% | ~1.5% (~$3B M&A) | Lower contribution |
| Capital return | $8.3B | ≥$9.3B (+12%) | Increasing |
Implied ramp: the Q1 FY26 guide of $18.1–18.75B implies +1–5% LC with a ~1.5% federal drag (AFS contracting mid-teens). Street at: the FY26 EPS range brackets the Street's ~$14 and the LC growth range sits modestly below the ~5–6% the Street had penciled — the soft side of in-line. Guidance style: classic Accenture conservatism — they set a wide range with the bottom allowing for deterioration and front-loaded the negatives (federal, restructuring). The margin and capital-return guides are arguably the most constructive elements and got the least attention.
Analyst Q&A Highlights
Whether AI is deflationary to Accenture's revenue base
The dominant line of questioning — the one the entire stock now turns on — pressed management on AI-driven productivity, potential deflationary effects, and the net impact on Accenture's services. Management rejected the deflation framing decisively.
Q: "Give us your latest thoughts on AI-driven productivity and those gains and how they might unfold... Do you see potential deflationary effects? How might that impact Accenture services, both positively and negatively?"
— Tien-tsin Huang, JPMorgan
A: "We do not see AI as deflationary. We do see and are seeing it as expansionary, similar to every tech evolution we've been through... Yes, AI absolutely boosts efficiency in areas like coding or operations. Those savings do not disappear. They're being reinvested into new priorities."
— Julie Sweet, Chair & CEO
Assessment: The clearest articulation yet of the bull thesis, and management has the tripled advanced-AI revenue to back the claim today. But it remains a forward-looking assertion; the gross-margin trend is the contrary data point that keeps it from being settled.
Savings and operating implications of the restructuring
Questioning sought to quantify the business-optimization program's savings and whether it, combined with internal AI use, structurally lifts utilization.
Q: "Can you talk about the assumed savings you expect to achieve from this optimization program... I'm specifically curious if you see that kind of combined with Gen AI adoption internally allowing you to operate at a sustainably higher utilization?"
— Bryan Bergin, TD Cowen
A: "We expect savings of over $1 billion from our business optimization program, which we expect that we will reinvest in our business and in our people... while still delivering modest margin expansion... we don't have a structural change in utilization due to AI."
— Julie Sweet, Chair & CEO
Assessment: Over $1B of savings reinvested while still expanding margin is a strong self-help story. The explicit "no structural utilization change from AI" tempers the most aggressive AI-margin-tailwind bull case — management is deliberately not promising that AI permanently re-rates the cost structure.
GenAI pricing and proof-of-concept-to-production velocity
A recurring topic probed the economics of GenAI work — whether pricing is accretive and whether projects are converting from pilots to production at scale.
Q: "How is the pricing of those projects evolving? Has the velocity of projects transitioning from proof of concept to production changed at all?"
— James Faucette, Morgan Stanley
A: "For our Gen AI projects... we do see pricing that is accretive overall to Accenture's average... we're seeing more and more now move into production because we're helping them with the proof of concept, and then we're helping them scale."
— Angie Park, CFO & Julie Sweet, CEO
Assessment: "Accretive pricing" on AI work is the single most important rebuttal to the pricing-pressure bear case, and it directly contradicts the gross-margin-erosion read. The reconciliation — accretive AI pricing yet falling gross margin — likely lies in mix (subcontractors, ramp costs) and is worth watching closely.
Why "advanced AI" excludes data
Questioning probed the definition of advanced AI (GenAI + agentic + physical) and why data — typically described as foundational — is excluded from the disclosed figure.
Q: "Why you're saying you're not including data because we've sort of been trained that data is foundational. Why is the data component not in the definition of advanced AI?"
— Jamie Friedman, Susquehanna
A: "Data is absolutely critical. In fact, one out of every two projects in Gen AI, Agentic AI, physical AI has significant data pull-through. Our data business is on fire... it's just that to date, we've wanted to share with all of you transparently the really new area."
— Julie Sweet, Chair & CEO
Assessment: A useful disclosure — the $2.7B advanced-AI figure understates total AI-driven revenue because it excludes the data pull-through (in half of all AI projects) and AI used in delivery. The true AI-adjacent revenue base is meaningfully larger than the headline, which is a quiet positive the market may be under-weighting.
FY26 headcount growth alongside the restructuring
Questioning sought to reconcile the commitment to grow headcount across all regions with the simultaneous severance program, and to frame the magnitude.
Q: "You expect headcount to grow during the course of the fiscal year across all regions. Can you maybe kind of frame for us the magnitude... given the context of some of the other business optimization actions?"
— Jim Schneider, Goldman Sachs
A: "We expect it to grow across all markets. We don't have a specific number that we're giving you, but based upon the demand that we see, we expect our headcount to grow."
— Angie Park, CFO
Assessment: Growing headcount into demand while restructuring the skill base is a confidence signal that demand is real, not a cost-cutting hunker-down. The refusal to size it is consistent with Accenture's "no direct correlation between headcount and revenue" stance.
Federal procurement, H-1B, and policy exposure
A multi-part question covered the federal procurement environment, potential H-1B visa changes, and other policy shifts.
Q: "Now that we have a little more clarity on tariffs, do you see more capital investment...? Maybe you could just comment on H-1B changes or potential changes... and how it may or may not impact the business?"
— Darrin Peller, Wolfe Research
A: "On H-1B visas, for us, this is really a non-issue because we only have about 5% of our people in the U.S. on H-1B visas... our business thrives by helping our clients navigate change... when you have new compliance rules, that usually drives more business for us."
— Julie Sweet, Chair & CEO
Assessment: The H-1B exposure (~5% of U.S. staff) is genuinely small and de-risks a headline that periodically spooks IT-services investors. The "policy change drives business" framing is self-serving but historically accurate for Accenture's compliance-adjacent work.
What They're NOT Saying
- A specific headcount-growth number for FY26. "It will grow" without magnitude leaves the most-watched proxy for the AI-vs-labor question deliberately fuzzy.
- A clean explanation for four quarters of gross-margin erosion. Management redirects to operating margin every time; the "accretive AI pricing" claim sits unreconciled against the gross-line trend.
- The split of the $865M charge between severance and divestitures. We know it's "two parts" but not the weighting — which matters for gauging how deep the talent rotation actually cuts.
- Quantified savings timing. "Over $1B reinvested" with "modest margin expansion" leaves unclear how much of the savings drops through versus gets spent — the bridge from $1B savings to only +10–30bps of margin implies heavy reinvestment that isn't itemized.
- Whether the FY26 +2–5% range contemplates further federal deterioration. Management sized the base-case federal drag but did not bound the downside if cancellations re-accelerate.
Market Reaction
- Pre-print setup: ACN entered the print at $239.08 (Sept 24 close) — down ~32% YTD and ~29% over the trailing 12 months, having slid roughly 18% from its ~$285 post-Q3 level over the summer. Sentiment was deeply negative; the de-rating had already priced a structurally slower algorithm.
- Reaction-day move: the stock opened roughly flat (-0.2%), traded an intraday range of $229.40–$242.00, and closed -2.7% at $232.56 (-$6.52) on ~10.4M shares (2.2x the 30-day average). The S&P 500 was down 0.5% on the day.
- 52-week context: the $232.56 close sat near the very bottom of the trailing 52-week closing range ($235.50–$398.25), effectively setting a new closing low.
A 2.7% drop on a clean beat, record cash, and a 12%-higher capital-return guide is, in context, a muted reaction — and the muting is the signal. After two quarters of the market punishing decelerating-and-disrupted narratives, the FY26 guide delivered the deceleration everyone feared, and the stock barely moved. That is what late-stage de-rating looks like: the bad news is in the price, and incrementally bad news no longer moves it much. The flat open and shallow close (versus Q3's -8% gap) suggest holders have largely re-based expectations. It is not yet capitulation-and-reversal, but the asymmetry is starting to shift.
Street Perspective
Debate: Has the AI-cannibalization fear peaked, or is the deceleration just beginning?
Bull view: the FY26 guide is the trough — federal is sized and rolling off after Q3, advanced-AI revenue tripled with accretive pricing, and management's "expansionary" framing plus the restructuring set up re-acceleration in FY27. The stock has discounted a far worse outcome than +5–8% EPS growth.
Bear view: +2–5% LC is the first formal step-down and the start of a multi-year grind lower as AI structurally compresses billable hours; the four-quarter gross-margin slide is the leading indicator, and "expansionary" is hope, not evidence.
Our take: the bull has the better near-term setup — the negatives are now sized and largely priced — but the bear's structural question remains genuinely open. The tripled AI revenue is the most encouraging data point in a year; the gross-margin trend is the most concerning. Until one of them resolves, this is a Hold, not an upgrade.
Debate: Is the restructuring a sign of strength or distress?
Bull view: rotating the pyramid while growing total headcount and funding it with $1B of self-help savings is exactly what a confident market leader does to get ahead of a technology shift — offense, not defense.
Bear view: a $865M severance-heavy charge to exit people who "can't be reskilled fast enough" is an admission that AI is reshaping the labor model faster than Accenture's organic re-skilling can absorb — a tell that the cannibalization is real.
Our take: both are true, and that's fine. The action is the correct one regardless of which narrative dominates; the question is execution on a compressed timeline. We read it as net-positive — management acting decisively beats management in denial — but it is not a reason to pay up today.
Debate: Is a ~17x multiple on a 5–8% grower cheap or fair?
Bull view: a best-in-class compounder with 1.2–1.4x FCF/NI conversion, a 10%-raised dividend, a fresh $5B buyback, and a fortress balance sheet at ~17x forward is the cheapest Accenture has been in a decade — generational value if growth merely stabilizes.
Bear view: ~17x is fair, not cheap, for a business whose growth just stepped to mid-single digits with an unresolved structural overhang; the multiple can compress further if FY26 lands at the low end.
Our take: the valuation has done enough work to neutralize the "expensive" objection that capped us at Hold in June — but not enough to create the asymmetry that justifies Outperform against a freshly-confirmed deceleration. We'd upgrade on either a further leg down (mid-teens multiple) or one quarter of execution that validates the "expansionary" thesis with stabilizing gross margin and re-accelerating consulting bookings.
Model Update Needed
| Item | Prior (post-Q3) | Updated | Reason |
|---|---|---|---|
| FY26 revenue growth (LC) | Model 2–4%, biased low | +2% to +5% (mid ~3.5%) | Management guide; federal sized at 1–1.5% |
| FY26 adj. EPS | n/a | $13.52–$13.90 | Guide; model ~$13.70 midpoint |
| FY26 adj. operating margin | ~15.6% | 15.7–15.9% | Guide; SG&A leverage + reinvested savings |
| Gross margin | Flat-to-down | Down ~25–50bps; watch | Fourth straight quarter of erosion |
| Inorganic contribution | ~2–3% | ~1.5% (~$3B M&A) | Lower contribution despite higher spend |
| FY26 FCF | ~$10B | $9.8–10.5B (1.2x) | Normalizing off the 1.4x FY25 |
| Capital return | ~$8.3B | ≥$9.3B (+12%) | Dividend +10%; +$5B buyback authority |
Valuation impact: at the $232.56 reaction close on ~$13.70 FY26 EPS, ACN trades ~17x forward — roughly its 10-year-low end and a clear discount to the ~22–25x it commanded in 2023–24. For a 5–8% EPS grower with elite FCF, ~17x is fair-to-modestly-attractive but not the high-conviction bargain a mid-teens multiple would represent. We frame fair value in the ~$240–260 range (≈17.5–19x), implying limited downside and modest upside from here — a balanced, Hold-consistent risk/reward.
Thesis Scorecard Post-Earnings
| Thesis Point | Status | Notes |
|---|---|---|
| Bull #1: Largest scaled beneficiary of enterprise AI | Strengthening | Advanced-AI revenue tripled to $2.7B; bookings ~doubled to $5.9B; pricing accretive |
| Bull #2: Best-in-class FCF + capital-return compounder | Confirmed | $10.9B FCF (+26%, 1.4x); dividend +10%; +$5B buyback; ≥$9.3B FY26 return |
| Bull #3: Diversified, resilient large-deal franchise | Confirmed | Record 129 $100M+ bookings; $80.6B FY bookings; 305 Diamond clients |
| Bear #1: AI cannibalizes labor-based delivery | Unresolved | Gross margin down 4 straight quarters; $865M talent-rotation charge validates the reshaping |
| Bear #2: Federal/DOGE drag | De-risking | Now sized (1–1.5% FY26), anniversaries end of Q3; procurement picking up |
| Bear #3: Decelerating organic algorithm | Confirmed | FY26 guide +2–5% LC vs. FY25 +7%; inorganic contribution down to ~1.5% |
Overall: Thesis modestly improved but still balanced. Two things got better since June — the federal overhang is now sized/de-risked, and the AI revenue scoreboard strengthened materially. Two things confirmed the caution — the FY26 growth step-down and persistent gross-margin erosion. Net: the bull case is gaining evidence while the central structural question stays open.
Action: Maintain Hold. The valuation now neutralizes the "too expensive" objection from June, and management is acting decisively, but a freshly-confirmed deceleration plus unresolved gross-margin pressure mean we still lack the asymmetry for Outperform. We are one good execution quarter — stabilizing gross margin, re-accelerating consulting bookings, or visible AI-led growth — away from upgrading. Q1 FY26 (December) is the swing.